DK2193802T3 - Neutraliserende monoklonale antistoffer mod med svært akut respirationssyndrom associeret coronavirus - Google Patents

Neutraliserende monoklonale antistoffer mod med svært akut respirationssyndrom associeret coronavirus

Info

Publication number
DK2193802T3
DK2193802T3 DK10151641.7T DK10151641T DK2193802T3 DK 2193802 T3 DK2193802 T3 DK 2193802T3 DK 10151641 T DK10151641 T DK 10151641T DK 2193802 T3 DK2193802 T3 DK 2193802T3
Authority
DK
Denmark
Prior art keywords
coronavirus
monoclonal antibodies
antibodies against
acute respiratory
respiratory syndrome
Prior art date
Application number
DK10151641.7T
Other languages
English (en)
Inventor
Shibo Jiang
Yuxian He
Original Assignee
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Ct Inc filed Critical New York Blood Ct Inc
Priority claimed from EP06720569A external-priority patent/EP1855719A4/en
Application granted granted Critical
Publication of DK2193802T3 publication Critical patent/DK2193802T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK10151641.7T 2005-02-08 2006-02-08 Neutraliserende monoklonale antistoffer mod med svært akut respirationssyndrom associeret coronavirus DK2193802T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65104605P 2005-02-08 2005-02-08
US14192505A 2005-05-31 2005-05-31
EP06720569A EP1855719A4 (en) 2005-02-08 2006-02-08 NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME

Publications (1)

Publication Number Publication Date
DK2193802T3 true DK2193802T3 (da) 2012-06-25

Family

ID=46282498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10151641.7T DK2193802T3 (da) 2005-02-08 2006-02-08 Neutraliserende monoklonale antistoffer mod med svært akut respirationssyndrom associeret coronavirus

Country Status (2)

Country Link
EP (1) EP2193802B1 (da)
DK (1) DK2193802T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230035217A (ko) * 2020-02-24 2023-03-13 인스티튜트 오브 마이크로바이올로지, 차이니즈 아카데미 오브 사이언스즈 2019 신규 코로나바이러스의 인간화 모노클로날 항체 및 그의 용도
EP4130035A4 (en) * 2020-03-31 2024-06-26 Bio Thera Solutions Ltd ANTIBODIES AND FUSION PROTEIN FOR THE TREATMENT OF CORONAVIRUS AND USE THEREOF
CN115916256A (zh) * 2020-04-24 2023-04-04 单细胞科技公司 抗sars冠状病毒2型刺突蛋白抗体
WO2021218879A1 (zh) * 2020-04-28 2021-11-04 神州细胞工程有限公司 Sars-cov-2中和抗体及其制备和应用
CN112017782A (zh) * 2020-06-01 2020-12-01 北京松果天目健康管理有限公司 SARS-CoV-2易感性的检测方法及新冠病毒重症风险预测方法
CN114252622A (zh) * 2020-09-23 2022-03-29 中国科学院大连化学物理研究所 一种体外筛选新型冠状病毒抑制剂的方法
CN112225814A (zh) * 2020-09-29 2021-01-15 东莞博盛生物科技有限公司 一种新型冠状病毒rbd融合蛋白亚单位疫苗及其制备方法和应用
CN113607957A (zh) * 2020-11-18 2021-11-05 广州中医药大学顺德医院(佛山市顺德区中医院) 一种针对SARS-CoV-2 RBD结构域的特异性中和抗体竞争法ELISA试剂盒
CN114685653B (zh) * 2020-12-31 2023-09-12 中国科学院分子细胞科学卓越创新中心 抗新冠病毒受体结合区域表位中和抗体及其应用

Also Published As

Publication number Publication date
EP2193802A2 (en) 2010-06-09
EP2193802A3 (en) 2010-09-01
EP2193802B1 (en) 2012-05-09

Similar Documents

Publication Publication Date Title
CY2019041I1 (el) Τροποποιημενα αντισωματα εναντι il-23
DK2059536T3 (da) Optimerede antistoffer, der er rettet mod cd19
CY2016030I1 (el) Αντισωματα εναντι της il-17
DK2193802T3 (da) Neutraliserende monoklonale antistoffer mod med svært akut respirationssyndrom associeret coronavirus
MA28936B1 (fr) Canalisation
IS8596A (is) Mótefni gegn CD154
NO344963B1 (no) Humanisert antistoff
DK1964852T3 (da) Anti-ilt7-antistof
DE602006000051D1 (de) Triebwerkslärm
DE602005015228D1 (de) Modifiziertes rekonstituiertes tabakblatt
NO20071430L (no) Anti-OX4OL antistoffer
DE602005020968D1 (de) n dafür
DK2035398T3 (da) Immobiliseret 1,2-benzisothioazolin-3-on
DE502006001728D1 (de) Schalldämpfer
ATE527362T1 (de) Verbesserte expression zeigendemodifizierte xylanasen
DE602007012234D1 (de) Schalldämpfer
NO20052035D0 (no) Stopemasse
DE602006004110D1 (de) Schalldämpfer
DE602006009608D1 (de) Synchronisierungseinrichtung
DE502006001058D1 (de) Synchronisiereinrichtung
FR2909834B1 (fr) Andaineuse transversale.
BRPI0718609A2 (pt) Anticorpos modificadores de doença cancerosa.
NL2001034A1 (nl) Krib.
DE602005013453D1 (de) Drosselklappe
TH110653B (th) P-แคดฮีรินแอนติบอดี